Canada markets closed

Ovation Science Inc. (OVAT.CN)

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Add to watchlist
0.4600-0.0300 (-6.12%)
At close: 3:59PM EDT

Ovation Science Inc.

625 Howe street
Suite 1140
Vancouver, BC V6C 2T6
Canada
604 283 0903
http://ovationscience.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Terry H. HowlettPres, CEO & Director72kN/A1948
Mr. Logan B. Anderson A.C.A., B.Com.CFO, Sec. & Director42kN/A1955
Ms. Doreen McMorranVP, COO & Director48kN/A1962
Mr. David K. RyanHead of Investor Relations & Director36kN/A1967
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Ovation Science Inc. engages in the production of cannabis or hemp products in Canada. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin products containing hemp seed oil and cannabis products under the Ovation brand. It holds sublicenses for cannabis based products in Canada and in the United States; and Lighthouse for licensed dispensaries in the United States. The company was founded in 2017 and is headquartered in Vancouver, Canada.

Corporate Governance

Ovation Science Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.